You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API norelgestromin and ethinyl estradiol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing norelgestromin and ethinyl estradiol

Detailed excipient profiles for norelgestromin and ethinyl estradiol

Excipient focus: CROSPOVIDONE

norelgestromin and ethinyl estradiol drug variants containing CROSPOVIDONE

Excipient focus: DIPROPYLENE GLYCOL

norelgestromin and ethinyl estradiol drug variants containing DIPROPYLENE GLYCOL

Excipient focus: LAURYL LACTATE

norelgestromin and ethinyl estradiol drug variants not containing LAURYL LACTATE

Excipient focus: MINERAL OIL

norelgestromin and ethinyl estradiol drug variants not containing MINERAL OIL

Excipient focus: OLEYL ALCOHOL

norelgestromin and ethinyl estradiol drug variants containing OLEYL ALCOHOL

Excipient focus: POLYBUTENE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.